[Ip-health] worrisome precedent?

George Carter gmcfiar at gmail.com
Fri May 15 05:47:50 PDT 2015

Merck wins Januvia patent case in India

May 15 2015, 07:16 ET | About: Merck & Co Inc. (MRK) | By: Douglas W. House, SA News Editor  
India's Supreme Court blocks Mumbai-based Glenmark Pharmaceuticals Ltd. from selling generic versions of Merck's (NYSE:MRK) diabetes drugs Januvia and Janumet, although Glenmark will be able to sell its existing inventory.
Merck sued Glenmark in 2013 for infringing on a patent covering sitagliptin, the active ingredient in its two drugs.

More information about the Ip-health mailing list